Femasys Inc. has announced a private placement with certain accredited investors, agreeing to sell senior secured convertible notes that are convertible into shares of the company's common stock at a conversion price of $0.73 per share. As part of the transaction, investors will also receive Series A-1, B-1, and C-1 warrants to purchase common stock at exercise prices of $0.81, $0.92, and $1.10 per share, respectively. The private placement is exempt from registration under the Securities Act and will be used to repay senior convertible notes issued in November 2023 and for general corporate purposes. Company insiders, including the CEO, CFO, and a board member, participated on the same terms as other investors, purchasing an aggregate of approximately $100,000 in notes and warrants. Femasys has also agreed to file a registration statement to register the resale of the conversion and warrant shares.